|
Christine Mary HallinanThe Conversation |
We’re seeing what happens when consumer demand collides with commercial interests for drugs including GLP-1s, psychedelics and testosterone. It’s...
More people are accessing medicinal cannabis than ever expected, or the health system was designed for. And we’re failing patients.